Quality Assurance and Batch Release Testing

This contract involves independent quality assurance testing of AMYVID batches, focusing on ensuring radiochemical purity, sterility, endotoxin levels, and accurate dose calibration. The testing is required to confirm compliance with current Good Manufacturing Practices (cGMP) and FDA standards, thereby ensuring the safety and effectiveness of the product before release. The work is set as a subcontract under the Department of Veterans Affairs, specifically managed by the 242-NETWORK Contract Office 02 (36C242). The contract falls under the NAICS code 541380, which pertains to testing laboratories, indicating the specialized nature of the services requested. Although specific details about the place of performance or point of contact are not provided, the contract posting date is May 26, 2026. The overall purpose is to maintain strict regulatory adherence and quality standards through rigorous testing protocols, supporting the safe distribution and use of AMYVID in clinical and medical settings.